During the course of his study, he researched on the area of drug resistance and pathogenesis in the Gram-negative bacteria, Burkholderia pseudomallei. His research also extended into the development of biomaterials with antimicrobial and anti-biofilm properties. Fadly also holds a Master’s degree in IP & Innovation Management (MIPIM) from the Singapore University of Social Sciences (SUSS).

Prior to joining Marks & Clerk, Fadly has worked in law firms and in a leading boutique intellectual property firm in Singapore, where he was involved in prosecuting a large portfolio of patent applications in various jurisdictions in Asia, Europe as well as the United States. Fadly has experience in drafting patent applications and has conducted numerous prior art searches for multinational corporations. In addition, he also has experience in providing validity/infringement opinions as well as freedom to operate analyses to large MNCs and other pharmaceutical companies. Fadly mainly focuses on inventions relating to life sciences, biotechnology, pharmaceutical sciences, nutritional sciences, bioengineering and medicine etc. 

He has been awarded two book prizes by the Association of Singapore Patent Attorneys (ASPA) for being the top scorer of Paper B (Amendment of a Patent Specification) and Paper C (Infringement and Validity of Singapore Patent) in the Patent Agents Qualifying Examinations.

Fadly is currently training to become a registered patent attorney in Singapore.